Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

4 terminated/withdrawn out of 12 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

58%

7 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 3
5(45.5%)
N/A
4(36.4%)
Phase 4
2(18.2%)
11Total
Phase 3(5)
N/A(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT05487053Not ApplicableRecruiting

The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement

Role: lead

NCT05209737Not ApplicableTerminated

Trendelenburg as a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients

Role: lead

NCT07422246Not ApplicableNot Yet Recruiting

Prognosis and Diagnosis of Acute Gastrointestinal Dysfunction in Cardiac Surgery Patients

Role: collaborator

NCT07200180Phase 3Recruiting

Perioperative Argon Inhalation to Improve Neurocognitive Recovery After Carotid Surgery

Role: lead

NCT05126238Phase 3Terminated

A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction

Role: lead

NCT05335109Phase 3Completed

Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction

Role: lead

NCT04820595Completed

Postoperative Neurocognitive Dysfunction: Is There Any Place for Emergency Agitation: A Prospective Cohort Trial

Role: lead

NCT04800393Not ApplicableRecruiting

The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.

Role: collaborator

NCT05259631Phase 3Suspended

Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS

Role: lead

NCT04453371Phase 3Withdrawn

Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)

Role: lead

NCT04287842Phase 4Withdrawn

Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R

Role: lead

NCT02133638Phase 4Unknown

Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery

Role: lead

All 12 trials loaded